Merck & Co (NY:MRK)

The healthcare stock could skyrocket if ivonescimab obtains approval from regulators, but there's still plenty of risk here.

Topics Intellectual Property

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? ↗

December 05, 2025

The rebound is well underway.

Is This Pharmaceutical Giant a Buy After a Major Acquisition? ↗

December 05, 2025

These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? ↗

Topics Death

December 05, 2025

After tepid performances throughout most of 2025, these stocks are showing some upward momentum.

Big Pharma Layoff Wave Extends Into Next Year: UNH, Merck, BMS, Novartis File New WARN Notices ↗

Topics Stocks

November 20, 2025

Via Stocktwits

Topics Workforce

Merck Says Its Two-Drug Regimen For HIV Treatment Proven Non-Inferior To Gilead’s Biktarvy In Study ↗

November 19, 2025

Via Stocktwits

With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026 ↗

December 05, 2025

Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new year.

These ETFs can provide me with lots of passive income.

Topics Artificial Intelligence Economy Stocks

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗

December 04, 2025

The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge,...

Topics ETFs Stocks

Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035

December 03, 2025

Wall Street has recently concluded a tumultuous yet ultimately resilient period, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all managing to edge higher in late November and...

Topics Artificial Intelligence Death Intellectual Property

Wall Street's Tentative Triumph: Dow, S&P 500, Nasdaq Edge Higher Amidst Shifting Tides

December 02, 2025

There's still time to get in on these rising stars.

Topics Artificial Intelligence Bonds Economy

2 Monster Stocks in the Making to Buy and Hold ↗

December 02, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

1 Value Stock to Target This Week and 2 We Question

December 01, 2025

As December 1, 2025, dawns, global financial markets are grappling with a significant uptick in Treasury yields, a movement primarily catalyzed by a substantial sell-off in Japanese government debt and...

Global Markets Brace as Treasury Yields Surge Amidst BOJ Speculation and Risk Aversion

December 01, 2025

Treasury Yields Surge Amid Global Shifts and Fiscal Concerns: A Deep Dive into Market Implications

Topics Bonds Economy Stocks

December 01, 2025

New York, NY – December 1, 2025 – U.S. Treasury yields have experienced a significant climb today, marking a pivotal moment for financial markets. This ascent, driven by a complex interplay of global...

These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Builders ↗

Topics Bonds Credit Cards Economy

November 30, 2025

If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio.

There are plenty of potential winners outside the world of AI.

Topics Energy Intellectual Property

3 Non-AI Stocks to Buy: MRK, UPS, CVX ↗

November 30, 2025

The struggling pharmaceutical giant is showing signs of life.

Topics Artificial Intelligence

Should You Buy This Blue Chip Pharmaceutical Stock That Just Popped 3.8%? ↗

November 29, 2025

The Dow Jones Industrial Average (DJIA) has staged a remarkable comeback, successfully erasing its November 2025 losses by the month's final trading day, Friday, November 28, 2025. This significant...

Dow Industrials Erase November Losses: A Beacon of Optimism Amidst Market Crossroads

November 28, 2025

Merck & Co. Inc. (NYSE:MRK): A Dividend Stock with Strong Profitability and Financial Health ↗

Topics Artificial Intelligence ETFs Economy

November 28, 2025

Discover Merck (MRK), a top dividend stock with a 3.58% yield, strong growth history, and excellent profitability for reliable income.

Via Chartmill

Dow Jones Navigates Volatility Amidst AI Bubble Fears and Shifting Fed Expectations

November 25, 2025

The Dow Jones Industrial Average has been on a roller-coaster ride in November 2025, experiencing significant volatility and sending mixed signals across various sectors. While the index achieved a...

Stocks making big moves yesterday: Meta, Tenet Healthcare, Wynn Resorts, Elevance Health, and Merck

Topics Artificial Intelligence Bonds Economy

November 25, 2025

Check out the companies making headlines yesterday:

Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 4.1% in the afternoon session after Wells Fargo upgraded the stock to "Overweight" from "Equal-Weight," citing confidence in the...

Topics Artificial Intelligence

Why Merck (MRK) Stock Is Trading Up Today

November 24, 2025

Q3 Earnings Outperformers: Merck (NYSE:MRK) And The Rest Of The Branded Pharmaceuticals Stocks

Topics Artificial Intelligence Economy

November 23, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Merck (NYSE:MRK) and the best and worst...

Mettler-Toledo, Agilent, Waters Corporation, Merck, and Regeneron Shares Skyrocket, What You Need To Know

Topics Artificial Intelligence Intellectual Property

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Goldman Sachs Just Delivered Bad News for U.S. Investors ... Sort Of. Here's What You Need to Know. ↗

Topics Economy World Trade

November 21, 2025

The investment bank's analysts simply recognize how much has changed in just the past few years, and what that means for the near future.

Merck Is Buying Cidara Therapeutics for $9.2 Billion. Is This the Boost the Lagging Drugmaker Needs? ↗

Topics Artificial Intelligence Economy

November 20, 2025

The pharmaceutical giant's post-Keytruda plans continue to take shape.

Shares in the biotech company have surged on news of a big pharma takeover.

Topics Intellectual Property

Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. ↗

November 20, 2025

Merck's Investigational Two-Drug Regime Matches Gilead's Three-Drug Tablet For HIV Treatment ↗

HIMS Has Been a Roller Coaster Ride. Should Investors Hop On? ↗

November 19, 2025

Via MarketBeat

November 19, 2025

Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.

Via Benzinga

2 Healthcare Stocks Worth Your Attention and 1 We Ignore

November 19, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and...